Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

LiDCO Says Results Of Study Using Its Cardiac Monitor Published

20th May 2014 14:56

LONDON (Alliance News) - LiDCO Group PLC Tuesday said a recent study published in the Journal of American Medical Association found that perioperative hemodynamic intervention is associated with a reduced complication rate and length of stay in hospital after surgery.

A test was conducted in 17 acute NHS hospitals to evaluate the clinical effectiveness of a peri-operative hemodynamic therapy algorithm on high-risk patients undergoing major gastrointestinal surgery.

LiDCO's LiDCOrapid monitor was the cardiac output monitoring system used in the trial.

LiDCO shares were quoted down 2.5% at 19.75 pence Tuesday.

By Anthony Tshibangu; [email protected]; @AnthonyAllNews

Copyright 2014 Alliance News Limited. All Rights Reserved.


Related Shares:

LID.L
FTSE 100 Latest
Value8,054.98
Change-419.76